441 related articles for article (PubMed ID: 28917273)
1. Mechanisms and risk factors of thrombosis in cancer.
Falanga A; Russo L; Milesi V; Vignoli A
Crit Rev Oncol Hematol; 2017 Oct; 118():79-83. PubMed ID: 28917273
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients.
Falanga A; Schieppati F; Russo L
Cancer Treat Res; 2019; 179():11-36. PubMed ID: 31317478
[TBL] [Abstract][Full Text] [Related]
3. Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer.
Falanga A; Schieppati F; Russo D
Semin Thromb Hemost; 2015 Oct; 41(7):756-64. PubMed ID: 26408922
[TBL] [Abstract][Full Text] [Related]
4. [Haemostatic aspects in clinical oncology].
Langer F; Holstein K; Eifrig B; Bokemeyer C
Hamostaseologie; 2008 Dec; 28(5):472-80. PubMed ID: 19132177
[TBL] [Abstract][Full Text] [Related]
5. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
Rak J; Klement P; Yu J
Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
[TBL] [Abstract][Full Text] [Related]
6. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
Falanga A; Marchetti M; Vignoli A; Balducci D
Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
[TBL] [Abstract][Full Text] [Related]
7. The prothrombotic state in cancer: pathogenic mechanisms.
De Cicco M
Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
[TBL] [Abstract][Full Text] [Related]
8. Flamethrowers: blood cells and cancer thrombosis risk.
Pabinger I; Posch F
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):410-7. PubMed ID: 25696887
[TBL] [Abstract][Full Text] [Related]
9. Microparticles and thrombotic disease.
Davizon P; López JA
Curr Opin Hematol; 2009 Sep; 16(5):334-41. PubMed ID: 19606028
[TBL] [Abstract][Full Text] [Related]
10. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilia in cancer.
Falanga A
Semin Thromb Hemost; 2005 Feb; 31(1):104-10. PubMed ID: 15706482
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor-bearing microparticles and cancer.
Zwicker JI
Semin Thromb Hemost; 2008 Mar; 34(2):195-8. PubMed ID: 18645925
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor and cancer.
Milsom C; Rak J
Pathophysiol Haemost Thromb; 2008; 36(3-4):160-76. PubMed ID: 19176989
[TBL] [Abstract][Full Text] [Related]
14. Role of tissue factor in hemostasis and thrombosis.
Mackman N
Blood Cells Mol Dis; 2006; 36(2):104-7. PubMed ID: 16466951
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
16. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
17. Tumour and microparticle tissue factor expression and cancer thrombosis.
Date K; Hall J; Greenman J; Maraveyas A; Madden LA
Thromb Res; 2013 Feb; 131(2):109-15. PubMed ID: 23237339
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of thrombosis in patients with malignancy.
Falanga A; Donati MB
Int J Hematol; 2001 Feb; 73(2):137-44. PubMed ID: 11372723
[TBL] [Abstract][Full Text] [Related]
19. Microparticles in hemostasis and thrombosis.
Owens AP; Mackman N
Circ Res; 2011 May; 108(10):1284-97. PubMed ID: 21566224
[TBL] [Abstract][Full Text] [Related]
20. [Disorders of hemostatic system in patients with malignant disease, especially in view of venous thromboembolism].
Bozóky G; Ruby E; Góhér I; Mohos A; Bálint C; Bozóky I
Orv Hetil; 2007 Sep; 148(36):1691-7. PubMed ID: 17766220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]